Skip to content

R&D at other companies

Stryker logo
StrykerSYK
$413M+2.0%
CONMED logo
CONMEDCNMD
$16.33M+26.2%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$103.4M-6.5%
Enovis logo
EnovisENOV
$31.53M+10.5%
OrthoPediatrics logo
OrthoPediatricsKIDS
$2.23M-5.1%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$15.32M-22.5%

Other financials

Income statement

See full
Revenue$47.2M-10.2%
Gross profit$37.4M-10.7%
Operating income-$17.2M-10.2%
Net income-$18.0M-12.8%
EPS (diluted)-$0.28-12.0%

Balance sheet

See full
Cash & equivalents$9.5M-28.6%
Total debt$71.6M+3.2%
Total equity$77.2M-26.7%
Total assets$184.1M-10.6%

Cash flow

See full
Operating cash flow$7.2M+72.5%
CapEx$3.1M-13.6%
Free cash flow$4.2M+538%

Valuation

See full
Market cap$258.19M-22.3%
Enterprise value$320.25M-19.0%
P/S1.3×-0.3×

Profitability

See full
Gross margin79.7%-0.5pp
Operating margin-26.9%+2.5pp
Net margin-29.4%+6.1pp
FCF margin-12.5%-2.8pp

Returns & leverage

See full
Return on equity-66.9%+57.5pp
Debt / equity0.9×+0.3×
Current ratio3.6×-0.9×

Where this comes from

Reported directly by Treace Medical Concepts, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Treace Medical Concepts, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Treace Medical Concepts, Inc.'s r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Treace Medical Concepts, Inc.'s R&D?
Treace Medical Concepts, Inc. (TMCI) reported R&D of $4.62M in Q1 2026.
How has Treace Medical Concepts, Inc.'s R&D changed year-over-year?
Treace Medical Concepts, Inc.'s R&D decreased by 16.9% year-over-year, from $5.56M to $4.62M.
What is the long-term trend for Treace Medical Concepts, Inc.'s R&D?
Over 4 years (2021 to 2025), Treace Medical Concepts, Inc.'s R&D has grown at a 18.7% compound annual growth rate (CAGR), from $10.2M to $20.28M.
What does R&D mean?
Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.